Cepivo BCG (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cepivo BCG" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

17nih.gov

4^th place

8^th place

14doi.org

2^nd place

5^th place

2termania.net

low place

34^th place

2web.archive.org

1^st place

2^nd place

1who.int

195^th place

64^th place

1tbsymptoms.net

low place

1archive.org

6^th place

9^th place

1worldcat.org

5^th place

10^th place

1usm.my

low place

archive.org

Tanghe, A.; J. Content; J. P. Van Vooren; F. Portaels; K. Huygen (2001). »Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer«. Infection and Immunity. 69 (9): 5403–5411. doi:10.1128/IAI.69.9.5403-5411.2001. PMC 98650. PMID 11500410.

doi.org

Colditz, Graham A.; Brewer, TF; Berkey, CS; Wilson, ME; Burdick, E; Fineberg, HV; Mosteller, F (1994). »Efficacy of BCG Vaccine in the Prevention of Tuberculosis«. JAMA. 271 (9): 698–702. doi:10.1001/jama.1994.03510330076038. PMID 8309034.
Fine PEM (1995). »Variation in protection by BCG: implications of and for heterologous immunity«. Lancet. 346 (8986): 1339–45. doi:10.1016/S0140-6736(95)92348-9. PMID 7475776.
Venkataswamy, Manjunatha M.; Goldberg, Michael F.; Baena, Andres; Chan, John; Jacobs, William R., Jr.; Porcelli, Steven A. (1. februar 2012). »In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG«. Vaccine. 30 (6): 1038–1049. doi:10.1016/j.vaccine.2011.12.044. PMC 3269512. PMID 22189700. {{navedi časopis}}: |access-date= potrebuje |url= (pomoč)
FINE, P (1. november 1995). »Variation in protection by BCG: implications of and for heterologous immunity«. The Lancet. 346 (8986): 1339–1345. doi:10.1016/S0140-6736(95)92348-9. PMID 7475776.
Roy A, Eisenhut M, Harris RJ, in sod. (2014). »Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis«. BMJ. 349: g4643. doi:10.1136/bmj.g4643. PMC 4122754. PMID 25097193.
Setia MS, Steinmaus C, Ho CS, Rutherford GW (2006). »The role of BCG in prevention of leprosy: a meta-analysis«. Lancet Infect Dis. 6 (3): 162–70. doi:10.1016/S1473-3099(06)70412-1. PMID 16500597.
Merle, Corinne SC; Cunha, Sergio S; Rodrigues, Laura C (2010). »BCG vaccination and leprosy protection: Review of current evidence and status of BCG in leprosy control«. Expert Review of Vaccines. 9 (2): 209–22. doi:10.1586/ERV.09.161. PMID 20109030.
Tanghe, A.; J. Content; J. P. Van Vooren; F. Portaels; K. Huygen (2001). »Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer«. Infection and Immunity. 69 (9): 5403–5411. doi:10.1128/IAI.69.9.5403-5411.2001. PMC 98650. PMID 11500410.
Rentsch, Cyrill A.; Birkhäuser, Frédéric D.; Biot, Claire; Gsponer, Joël R.; Bisiaux, Aurélie; Wetterauer, Christian; Lagranderie, Micheline; Marchal, Gilles; Orgeur, Mickael; Bouchier, Christiane; Bachmann, Alexander; Ingersoll, Molly A.; Brosch, Roland; Albert, Matthew L.; Thalmann, George N. (1. oktober 2014). »Bacillus Calmette-Guérin Strain Differences Have an Impact on Clinical Outcome in Bladder Cancer Immunotherapy«. European Urology. 66 (4): 677–688. doi:10.1016/j.eururo.2014.02.061. {{navedi časopis}}: |access-date= potrebuje |url= (pomoč)
Brandau, S.; Suttmann, H. (2007). »Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement«. Biomed Pharmacother. 61: 299–305. doi:10.1016/j.biopha.2007.05.004. {{navedi časopis}}: |access-date= potrebuje |url= (pomoč)
Lamm DL, Blumenstein BA, Crawford ED (1991). »A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder«. N Engl J Med. 325 (2): 1205–9. doi:10.1056/NEJM199110243251703. PMID 1922207.
Cuello-García, Carlos A.; Pérez-Gaxiola, Giordano; Jiménez Gutiérrez, Carlos (1. januar 2013). »Treating BCG-induced disease in children«. The Cochrane Database of Systematic Reviews. 1: CD008300. doi:10.1002/14651858.CD008300.pub2. ISSN 1469-493X. PMID 23440826.
Trunz BB, Fine P, Dye C (2006). »Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness«. Lancet. 367 (9517): 1173–80. doi:10.1016/S0140-6736(06)68507-3. PMID 16616560.
Mak TK, Hesseling AC, Hussey GD, Cotton MF (2008). »Making BCG vaccination programs safer in the HIV era«. Lancet. 372 (9641): 786–7. doi:10.1016/S0140-6736(08)61318-5. PMID 18774406.

nih.gov

pubmed.ncbi.nlm.nih.gov

Colditz, Graham A.; Brewer, TF; Berkey, CS; Wilson, ME; Burdick, E; Fineberg, HV; Mosteller, F (1994). »Efficacy of BCG Vaccine in the Prevention of Tuberculosis«. JAMA. 271 (9): 698–702. doi:10.1001/jama.1994.03510330076038. PMID 8309034.
Fine PEM (1995). »Variation in protection by BCG: implications of and for heterologous immunity«. Lancet. 346 (8986): 1339–45. doi:10.1016/S0140-6736(95)92348-9. PMID 7475776.
Venkataswamy, Manjunatha M.; Goldberg, Michael F.; Baena, Andres; Chan, John; Jacobs, William R., Jr.; Porcelli, Steven A. (1. februar 2012). »In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG«. Vaccine. 30 (6): 1038–1049. doi:10.1016/j.vaccine.2011.12.044. PMC 3269512. PMID 22189700. {{navedi časopis}}: |access-date= potrebuje |url= (pomoč)
FINE, P (1. november 1995). »Variation in protection by BCG: implications of and for heterologous immunity«. The Lancet. 346 (8986): 1339–1345. doi:10.1016/S0140-6736(95)92348-9. PMID 7475776.
Roy A, Eisenhut M, Harris RJ, in sod. (2014). »Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis«. BMJ. 349: g4643. doi:10.1136/bmj.g4643. PMC 4122754. PMID 25097193.
Setia MS, Steinmaus C, Ho CS, Rutherford GW (2006). »The role of BCG in prevention of leprosy: a meta-analysis«. Lancet Infect Dis. 6 (3): 162–70. doi:10.1016/S1473-3099(06)70412-1. PMID 16500597.
Merle, Corinne SC; Cunha, Sergio S; Rodrigues, Laura C (2010). »BCG vaccination and leprosy protection: Review of current evidence and status of BCG in leprosy control«. Expert Review of Vaccines. 9 (2): 209–22. doi:10.1586/ERV.09.161. PMID 20109030.
Tanghe, A.; J. Content; J. P. Van Vooren; F. Portaels; K. Huygen (2001). »Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer«. Infection and Immunity. 69 (9): 5403–5411. doi:10.1128/IAI.69.9.5403-5411.2001. PMC 98650. PMID 11500410.
Lamm DL, Blumenstein BA, Crawford ED (1991). »A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder«. N Engl J Med. 325 (2): 1205–9. doi:10.1056/NEJM199110243251703. PMID 1922207.
Cuello-García, Carlos A.; Pérez-Gaxiola, Giordano; Jiménez Gutiérrez, Carlos (1. januar 2013). »Treating BCG-induced disease in children«. The Cochrane Database of Systematic Reviews. 1: CD008300. doi:10.1002/14651858.CD008300.pub2. ISSN 1469-493X. PMID 23440826.
Centers for Disease Control and Prevention (1996). »The role of BCG vaccine in the prevention and control of tuberculosis in the United States: a joint statement of the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices«. MMWR Recomm Rep. 45 (RR-4): 1–18. PMID 8602127.
WHO (2007). »Revised BCG vaccination guidelines for infants at risk for HIV infection«. Wkly Epidemiol Rec. 82 (21): 193–6. PMID 17526121.
Trunz BB, Fine P, Dye C (2006). »Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness«. Lancet. 367 (9517): 1173–80. doi:10.1016/S0140-6736(06)68507-3. PMID 16616560.
Mak TK, Hesseling AC, Hussey GD, Cotton MF (2008). »Making BCG vaccination programs safer in the HIV era«. Lancet. 372 (9641): 786–7. doi:10.1016/S0140-6736(08)61318-5. PMID 18774406.

ncbi.nlm.nih.gov

Venkataswamy, Manjunatha M.; Goldberg, Michael F.; Baena, Andres; Chan, John; Jacobs, William R., Jr.; Porcelli, Steven A. (1. februar 2012). »In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG«. Vaccine. 30 (6): 1038–1049. doi:10.1016/j.vaccine.2011.12.044. PMC 3269512. PMID 22189700. {{navedi časopis}}: |access-date= potrebuje |url= (pomoč)
Roy A, Eisenhut M, Harris RJ, in sod. (2014). »Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis«. BMJ. 349: g4643. doi:10.1136/bmj.g4643. PMC 4122754. PMID 25097193.
Tanghe, A.; J. Content; J. P. Van Vooren; F. Portaels; K. Huygen (2001). »Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer«. Infection and Immunity. 69 (9): 5403–5411. doi:10.1128/IAI.69.9.5403-5411.2001. PMC 98650. PMID 11500410.

tbsymptoms.net

»BCG Vaccine | TB Symptoms | Tuberculin Skin Test | PPD | TB Signs«. TB Symptoms. 18. januar 2013. Arhivirano iz prvotnega spletišča dne 29. oktobra 2013. Pridobljeno 2. februarja 2014.

termania.net

http://www.termania.net/slovarji/slovenski-medicinski-slovar/5507821/bcg?query=BCG&SearchIn=All, Slovenski medicinski e-slovar, vpogled: 31. 5. 2016.
http://www.termania.net/slovarji/slovenski-medicinski-slovar/5509526/cepivo?query=cepivo&SearchIn=All, Slovenski medicinski e-slovar, vpogled: 31. 5. 2016.

usm.my

mjms.usm.my

Govindarajan KK, Chai FY (2011). »BCG adenitis — need for increased awareness«. Mal J Med Sci. 18 (2): 67–70. Malaysian Journal of Medical Sciences Arhivirano 2012-03-26 na Wayback Machine.

web.archive.org

»BCG Vaccine | TB Symptoms | Tuberculin Skin Test | PPD | TB Signs«. TB Symptoms. 18. januar 2013. Arhivirano iz prvotnega spletišča dne 29. oktobra 2013. Pridobljeno 2. februarja 2014.
Govindarajan KK, Chai FY (2011). »BCG adenitis — need for increased awareness«. Mal J Med Sci. 18 (2): 67–70. Malaysian Journal of Medical Sciences Arhivirano 2012-03-26 na Wayback Machine.

who.int

»BCG Vaccine: WHO position paper« (PDF). Weekly epidemiological record. 4 (79): 25–40. 23. januar 2014.

worldcat.org

Cuello-García, Carlos A.; Pérez-Gaxiola, Giordano; Jiménez Gutiérrez, Carlos (1. januar 2013). »Treating BCG-induced disease in children«. The Cochrane Database of Systematic Reviews. 1: CD008300. doi:10.1002/14651858.CD008300.pub2. ISSN 1469-493X. PMID 23440826.